References
- Bagshawe K D. Personal communication. Contemporary Gynaecology, G C Chamberlain. Butterworths, London 1980; 280
- Benjapibal M, Wataganara T, Senawong S, Boriboonhirunsarn D, Suphanit I. Correlation of beta subunit hCG levels in serum and first morning urine of patients with gestational trophoblastic disease. Journal of the Medical Association of Thailand 2001; 84: 1000–1005
- Birken S, Kovalevskaya G, O'Connor J. Metabolism of hCG and hLH to multiple urinary forms. Molecular and Cellular Endocrinology 1996; 125: 121–131
- Cole L A, Butler S, Shohkreh S, Behrman H, Newlands E S, Mitchell H, Verrill H. Utility of commonly used commercial hCG immunoassays in the diagnosis and management of trophoblastic diseases. Clinical Chemistry 2001; 47(2)308–315
- Hoermann R, Spoetti G, Grossmann M, Saller B, Mann K. Molecular heterogeneity of hCG in serum and urine of patients with trophoblastic tumours. Clinical Investigator 1993; 71: 953–960
- Kalenga M K, de-Hertogh R, Loumaye E, Vankrieken L, Thomas K. An evaluation method for determination and monitoring of urinary hCG. Reviews in French Gynecology and Obstetrics 1990; 85: 167–173
- Kennedy R L, Sheridan E, Darne J, Griffiths H, Davies R, Price A, et al. Thyroid function in choriocarcinoma. Clinical Endocrinology 1990; 33: 227–237
- Mann K, Schneider N, Hoermann R. Acidic isoelectric variants of hCG from trophoblastic tumours. Endocrinology 1986; 118: 1558–1566
- Meyer T, Cole L, Richman P, Mitchell H, Myers J, Rustin G. High levels of hCG in choriocarcinoma can result in renal failure and a false-negative pregnancy test in men. Clinical Oncology 2001; 13: 301–303
- Sutton J M. Charge variants in serum and urine hCG. International Journal of Clinical Chemistry 2004; 341: 199–203